Zhou Ming-Sheng, Jaimes Edgar A, Raij Leopoldo
Nephrology and Hypertension Section, Veterans Affairs Medical Center, 1201 NW 16th Street, Miami, FL 33125, USA.
Am J Hypertens. 2004 Feb;17(2):167-71. doi: 10.1016/j.amjhyper.2003.09.007.
Calcium channel blockers such as amlodipine are effective antihypertensive agents. In this study we investigated the effects of amlodipine on vascular oxidative stress, expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1), and endothelial function in angiotensin (Ang) II-infused rats.
Sprague-Dawley rats were treated with Ang II (0.7 mg/kg/day subcutaneously injected by mini-pump), with or without amlodipine (10 mg/kg/day by gavage), for 5 days and compared with control rats. Levels of aortic ring superoxide (O(2)(-)) and peroxynitrite (ONOO(-)) were determined, and systolic blood pressure (SBP) and endothelium-dependent relaxation were evaluated.
Compared with control rats, Ang II-infused rats developed hypertension (175 +/- 3 v 135 +/- 2 mm Hg, P <.05), aortic hypertrophy (16.9 +/- 1.3 v 13.2 +/- 0.3 mg/cm, P <.05), left ventricular hypertrophy (0.236 +/- 0.003 v 0.204 +/- 0.004 g/100 g body weight, P <.05), and impaired endothelium-dependent relaxation (ED(50): 6.6 +/- 0.2 v 8.0 +/- 0.2 -log mol/L acetylcholine concentration, P <.05). Compared with control rats, Ang II-infused rats also had higher aortic levels of LOX-1 mRNA expression, O(2)(-)production (1005 +/- 140 v 608 +/- 159 counts/min/mg, P <.05), ONOO(-) production (1875 +/- 295 v 782 +/- 115 counts/min/mg, P <.05), and plasma free 8-F(2)alpha-isoprostanes (67.4 +/- 19.1 v 27.2 +/- 6.1 pg/mL, P <.05). In Ang II-infused rats SBP, aortic hypertrophy, endothelial dysfunction, LOX-1 expression, aortic O(2)(-) and ONOO(-) production, and plasma free 8-F(2)alpha-isoprostane levels were significantly reduced by amlodipine treatment.
Amlodipine has antihypertensive and antioxidant activity in vivo, which effectively inhibits many of the oxidative stress-dependent mechanisms involved in Ang II-mediated cardiovascular injury.
氨氯地平等钙通道阻滞剂是有效的抗高血压药物。在本研究中,我们调查了氨氯地平对血管紧张素(Ang)II输注大鼠的血管氧化应激、凝集素样氧化低密度脂蛋白受体(LOX-1)表达及内皮功能的影响。
将Sprague-Dawley大鼠用Ang II(通过微型泵皮下注射,0.7 mg/kg/天)处理,有或无氨氯地平(通过灌胃,10 mg/kg/天),持续5天,并与对照大鼠进行比较。测定主动脉环超氧化物(O₂⁻)和过氧亚硝酸盐(ONOO⁻)水平,并评估收缩压(SBP)和内皮依赖性舒张功能。
与对照大鼠相比,输注Ang II的大鼠出现高血压(175±3对135±2 mmHg,P<.05)、主动脉肥厚(16.9±1.3对13.2±0.3 mg/cm,P<.05)、左心室肥厚(0.236±0.003对0.204±0.004 g/100 g体重,P<.05)以及内皮依赖性舒张功能受损(ED₅₀:6.6±0.2对8.0±0.2 -log mol/L乙酰胆碱浓度,P<.05)。与对照大鼠相比,输注Ang II的大鼠主动脉中LOX-1 mRNA表达水平、O₂⁻生成量(1005±140对608±159计数/分钟/毫克,P<.05)、ONOO⁻生成量(1875±295对782±115计数/分钟/毫克,P<.05)以及血浆游离8-F₂α-异前列腺素水平(67.4±19.1对2